🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

4 Stocks To Watch: BLUE, CORT, KEM, LOXO

Published 09/01/2017, 12:18 AM
Updated 07/09/2023, 06:31 AM
AUDC
-
ARRY_old
-
AVAV
-
CORT
-
DIOD
-
DVAX
-
HIMX
-
AMRX
-
SPPI
-
PRTK
-
KEM_old
-
SUPN
-
BLUE
-
CSTM
-
CYRX
-
RXDX_old
-
JMEI_old
-
LOXO
-
JNUG
-
FGEN
-
CRBP
-
LABU
-
MTCH
-
NTLA
-
HTZGQ
-

bluebird bio, Inc. (NASDAQ:BLUE) had a big day on Thursday. It pulled back after the breakout four days ago, and held the moving average and the prior breakout point. It exploded, and on Thursday, it ran really hard, jumping 12.35, or 11%, to 124.85, on 2.8 million shares traded. In the last two days, it has gone from 102.80 to 125.60, about 23 points. Thursday’s high is right where it was back in June. I’m looking for this stock to make a run to 140-44. I think if it gets some back and forth action in the next few days, that might be a buying opportunity. The long-term chart looks incredible. It has 12.35 days to cover .

Swing trade Corcept Therapeutics Incorporated (NASDAQ:CORT) is working out great, gaining 1.13, or 7%, to 16.67, on 3 million shares traded. It’s been up four days in a row and reached 17.06, which was my swing target. My next target is 19. It has 6 days to cover .

KEMET Corporation (NYSE:KEM) just keeps rocking, up another 83 cents, or 3.6%, to 23.91, on 2.7 million shares traded on Thursday, and reaching a high as 24.17. I gave this one to you last Nov-Dec at 5.25, and its up 300% since then, and continues to fly. My next target is 29-30.

Loxo Oncology, Inc. (NASDAQ:LOXO), a swing trade of ours, was up 4.18, or 5%, to 83.40, on 348,016 shares traded on Thursday. It is right up against the double-top from June. If it gets through there, it could rock up to 100-05. Stay tuned on this one. It has 15.7 days to cover .

On the long side, stocks included AudioCodes Ltd. (NASDAQ:AUDC), Array BioPharma Inc. (NASDAQ:ARRY), AeroVironment, Inc. (NASDAQ:AVAV), bluebird bio, Inc. (BLUE), Corcept Therapeutics Incorporated (CORT), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), Constellium N.V (NYSE:CSTM), Cryoport, Inc. (NASDAQ:CYRX), Diodes Incorporated (NASDAQ:DIOD), Dynavax Technologies Corporation (NASDAQ:DVAX), FibroGen, Inc. (NASDAQ:FGEN), Himax Technologies, Inc. (NASDAQ:HIMX), Hertz Global Holdings, Inc. (NYSE:HTZ), Impax Laboratories Inc. (NASDAQ:IPXL), Jumei International Holding Limited (NYSE:JMEI), Direxion Daily Jr Gld Mnrs Bull 3X ETF (NYSE:JNUG), KEMET Corporation (NYSE:KEM), Direxion Daily S&P Biotech Bull 3X ETF (NYSE:LABU), Loxo Oncology, Inc. (NASDAQ:LOXO), Match Group, Inc. (NASDAQ:MTCH), Intellia Therapeutics Inc. (NASDAQ:NTLA), Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), Ignyta, Inc. (NASDAQ:RXDX), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), and Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN).

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.